IL10 and neoplasm: These neuroendocrine mediators elevate inflammatory cytokines (e.g., IL-6, IL-8) and immunosuppressive cytokines (e.g., IL-4, IL-10, VEGF), suppressing NK cell and Tc cell activity while promoting regulatory T (Treg) cell expansion, ultimately contributing to tumor progression [5].